Good evening
Good evening
Guest
Please welcome Chopogordon87, our newest member.

75 Guests, 0 Users
August 2017
SunMonTueWedThuFriSat
12345
6789101112
13141516171819
20212223242526
2728293031
Holidays
Sep 4: Labor Day
Sep 11: Patriot Day
Sep 22: Autumnal Equinox
 

Steve.Deserved.Better

June 19, 2017, 09:17:36 AM
It's Summer in Ohio finally!  Enjoy and have a safe one!
 

Steve.Deserved.Better

April 24, 2017, 06:51:59 PM
If you mean, me myself and I.  Then yes.  Hey Runner!!! How ya doing?!
 

runner76

April 23, 2017, 09:32:38 PM
Steve.Deserved.Better, do you mean 'I am he as you are he as you are me
and we are all together"?




 

Steve.Deserved.Better

April 17, 2017, 09:25:21 AM
You were here and I wasn't and now I'm here and you aren't.  Have a great day!!
 

"V"

April 17, 2017, 07:41:44 AM
?????

HHS supporting study of Zika virus blood screening test


April 22, 2016 - 10:51 AM



The development of a test to identify whether donated blood is infected with the Zika virus is moving forward with support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and the Office of the Assistant Secretary for Health (OASH).

On March 30, the U.S. Food and Drug Administration (FDA) announced the availability of an investigational test to screen blood donations for Zika virus. The test is manufactured by Roche Molecular Systems, Inc., based in Branchburg, New Jersey.

Today’s agreement with ASPR’s Biomedical Advanced Research and Development Authority (BARDA) supports a clinical study to evaluate the sensitivity and specificity of the blood donation screening test in its actual use. The study is necessary to apply for FDA approval for commercial marketing.

“BARDA staff has worked closely with our partners at FDA and the Office of the Assistant Secretary of Health to ensure the continuity and safety of the U.S. blood supply,” said Dr. Richard Hatchett, BARDA’s acting director. “Today’s award to Roche is an important step towards securing the safety of the blood supply in Puerto Rico and in the rest of the United States.”

Most people infected with Zika do not have symptoms and may donate blood not knowing that they are infected. There have been reports of probable cases of transfusion transmission of Zika virus in Brazil, and those cases currently are being investigated. Having an accurate blood donation screening test will help ensure that infected blood is removed from the blood supply. 

Under the one-year, $354,500 contract, Roche will study blood samples to confirm whether the test accurately and reliably detects and identifies Zika virus, even when present in very low concentration in donor blood.  

Advancing the development of the Zika virus blood donation screening test is part of BARDA’s integrated portfolio for advanced research and development, innovation, acquisition, and manufacturing of vaccines, drugs, diagnostic tools, and non-pharmaceutical products for public health emergency threats. These threats include chemical, biological, radiological, and nuclear agents, pandemic influenza, emerging infectious diseases, and antimicrobial resistance.

Share on Facebook! Share on Twitter! g+ Reddit Digg this story! Del.icio.us StumbleUpon

Comments *

You don't have permmission to comment, or comments have been turned off for this article.